Literature DB >> 9579153

Clinical presentation and outcome in primary familial hypomagnesaemia.

H Shalev1, M Phillip, A Galil, R Carmi, D Landau.   

Abstract

The clinical presentation and long term outcome (mean follow up eight years, range 0.25 to 21) of 15 patients with autosomal recessive primary familial hypomagnesaemia is described. The most common (67%) presenting events were generalised hypocalcaemic-hypomagnesaemic seizures at a mean (SD) age of 4.9 (2.5) weeks. Thirteen infants, treated soon after diagnosis with high dose enteral magnesium developed normally. Their serum calcium returned to normal concentrations but serum magnesium could not be maintained at normal concentrations (0.53 (0.12 SD) mmol/l; normal > 0.62). Delay in establishing a diagnosis led to a convulsive disorder with permanent neurological impairment in two infants. Reported complications of prolonged hypomagnesaemia such as renal stones, hypertension, arrhythmias, sudden death, or dyslipidaemia were not observed.

Entities:  

Mesh:

Year:  1998        PMID: 9579153      PMCID: PMC1717462          DOI: 10.1136/adc.78.2.127

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  29 in total

1.  Effect of a chronic suboptimal intake of magnesium on magnesium and calcium content of bone and on bone strength of the rat.

Authors:  O Héroux; D Peter; A Tanner
Journal:  Can J Physiol Pharmacol       Date:  1975-04       Impact factor: 2.273

2.  Idiopathic hypoparathyroidism presenting as dementia.

Authors:  D Eraut
Journal:  Br Med J       Date:  1974-03-09

3.  Congenital primary hypomagnesemia, an inborn error of metabolism?

Authors:  D Skyberg; J H Stromme; R Nesbakken; K Harnaes
Journal:  Acta Paediatr Scand       Date:  1967

4.  Impaired release of parathyroid hormone in magnesium deficiency.

Authors:  C S Anast; J L Winnacker; L R Forte; T W Burns
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

5.  Familial hypomagnesemia--a follow-up examination of three patients after 9 to 12 years of treatment.

Authors:  J H Strømme; J Steen-Johnsen; K Harnaes; F Hofstad; P Brandtzaeg
Journal:  Pediatr Res       Date:  1981-08       Impact factor: 3.756

6.  Congenital hypomagnesemia: alternatives to tissue biopsies for monitoring body magnesium status.

Authors:  O Guillard; R Mettey; J C Lecron; A Pineau
Journal:  Clin Biochem       Date:  1992-12       Impact factor: 3.281

7.  [Primary hypomagnesemia. Clinical, diagnostic and therapeutic studies in three children (author's transl)].

Authors:  K Becker; I Lombeck; H J Bremer
Journal:  Monatsschr Kinderheilkd       Date:  1979-01

8.  Studies in primary hypomagnesaemia: evidence for defective carrier-mediated small intestinal transport of magnesium.

Authors:  P J Milla; P J Aggett; O H Wolff; J T Harries
Journal:  Gut       Date:  1979-11       Impact factor: 23.059

9.  Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.

Authors:  R K Rude; S B Oldham; F R Singer
Journal:  Clin Endocrinol (Oxf)       Date:  1976-05       Impact factor: 3.478

10.  Magnesium metabolism in renal stone disease.

Authors:  G Johansson; U Backman; B G Danielson; S Ljunghall; B Wikström
Journal:  Invest Urol       Date:  1980-09
View more
  22 in total

1.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis in three siblings having the same genetic lesion but different clinical presentations.

Authors:  Hilary H Seeley; Lindsey A Loomba-Albrecht; Mato Nagel; Lavjay Butani; Andrew A Bremer
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

Review 2.  Molecular basis of epithelial Ca2+ and Mg2+ transport: insights from the TRP channel family.

Authors:  Henrik Dimke; Joost G J Hoenderop; René J M Bindels
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

3.  Mild hypotonia and recurrent seizures in an 8-month-old boy: Answers.

Authors:  Sare Gülfem Özlü; Cigdem Seher Kasapkara; Serdar Ceylaner; Meryem Erat Nergız; Başak Alan; Songül Yılmaz; Ayşegül Neşe Çıtak Kurt
Journal:  Pediatr Nephrol       Date:  2019-03-22       Impact factor: 3.714

Review 4.  Genetic kidney diseases in the pediatric population of southern Israel.

Authors:  Gal Finer; Hanna Shalev; Daniel Landau
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

Review 5.  A critical role of TRPM channel-kinase for human magnesium transport.

Authors:  Karl P Schlingmann; Thomas Gudermann
Journal:  J Physiol       Date:  2005-04-21       Impact factor: 5.182

6.  Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development.

Authors:  Hao Zhou; David E Clapham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

7.  Mice defective in Trpm6 show embryonic mortality and neural tube defects.

Authors:  Roxanne Y Walder; Baoli Yang; John B Stokes; Patricia A Kirby; Xiao Cao; Peijun Shi; Charles C Searby; Russell F Husted; Val C Sheffield
Journal:  Hum Mol Genet       Date:  2009-08-18       Impact factor: 6.150

8.  CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Martin Konrad; Jianghui Hou; Stefanie Weber; Jörg Dötsch; Jameela A Kari; Tomas Seeman; Eberhard Kuwertz-Bröking; Amira Peco-Antic; Velibor Tasic; Katalin Dittrich; Hammad O Alshaya; Rodo O von Vigier; Sabina Gallati; Daniel A Goodenough; André Schaller
Journal:  J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 10.121

Review 9.  Genetics of hereditary disorders of magnesium homeostasis.

Authors:  Karl P Schlingmann; Martin Konrad; Hannsjörg W Seyberth
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

10.  Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women.

Authors:  Yiqing Song; Yi-Hsiang Hsu; Tianhua Niu; Joann E Manson; Julie E Buring; Simin Liu
Journal:  BMC Med Genet       Date:  2009-01-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.